Last update Jan. 15, 2021
Very Low Risk
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
تولبوتاميد is Tolbutamide in Arabic.Is written in other languages:
تولبوتاميد is also known as
تولبوتاميد belongs to these groups or families:
|Tmax||3 - 5||hours|
|T½||4.5 - 6.5||hours|
|Theoretical Dose||0.00045 - 0.0027||mg/Kg/d|
|Relative Dose||0.004% - 0.02%||%|
Write us at firstname.lastname@example.org
e-lactancia is a resource recommended by Asociación Española de Bancos de Leche Humana of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Sulfonylurea that stimulates endogenous insulin secretion. May cause hypoglycemia.
Indicated in the treatment of type 2 diabetes.
Oral administration in one to three doses daily.
It is excreted in breast milk in clinically insignificant amounts (Moiel 1967).
Experts authors consider the use of this medication to be safe during breastfeeding (Serrano 2015).
American Academy of Pediatrics: medication usually compatible with breastfeeding (AAP 2001).
Diet, exercise, and breastfeeding improve blood sugar levels.
See below the information of this related product: